{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T17:55:14Z","timestamp":1778954114144,"version":"3.51.4"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T00:00:00Z","timestamp":1715904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>The COVID vaccination program with new types of vaccinations and early reports of allergic reactions to vaccines led to vaccination hesitancy in patients with allergies. In this study, we aimed to characterize patients who present at an allergy center with specific questions regarding risk assessment to COVID vaccines in comparison to regular allergy center patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 50 patient charts of patients with risk assessment for COVID vaccination (COV group) and 50 regular allergy center patients (ALL group) were assessed for documented allergies, comorbidities, total IgE, and tryptase levels and hospital anxiety and depression score (HADS). Skin prick testing (SPT) with additives of COVID vaccines [polyethylene glycol (PEG), polysorbate] were performed if indicated based on medical history.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Patients who presented for examination prior to a possible COVID vaccination were mostly female (86%) and had more frequently reported allergic reactions to drugs in the past, but only in a minor group (28%) were the reactions qualified as anaphylaxis. The group COV patients scored significantly higher in the HADS for anxiety and depression than the regular group ALL patients. The same trend was observed when data were corrected for gender. It is worth noting that patients without any prior contact to COVID vaccines scored comparable regarding anxiety to patients with prior reaction to COVID vaccinations, but significantly higher in the depression score. In 19 patients (38%) who met the indications for SPT for the suspicious contents PEG and Polysorbate 80, the tests did not show a positive result. Furthermore, 84% of patients underwent the prick test, but only 15% of patients who received consultation alone agreed to vaccination at our center. No vaccination-related event was documented in these patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>In conclusion, vaccination hesitancy was frequently elicited by negative experiences with drugs and putative drug allergies. Female patients predominate in this patient group, and the anxiety and depression scores were significantly elevated. Allergological workup, including SPT, led to a high rate of subsequent vaccinations, whereas a discussion with the patients about risks and individualized advice for vaccination without testing only rarely resulted in documented vaccinations.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2024.1324987","type":"journal-article","created":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T04:25:11Z","timestamp":1715919911000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Vaccine hesitancy in patients presenting to a specialized allergy center: clinical relevant sensitizations, impact on mental health and vaccination rates"],"prefix":"10.3389","volume":"15","author":[{"given":"Natalie","family":"Kogseder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viktoria","family":"Puxkandl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfram","family":"Hoetzenecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Altrichter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,5,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1037\/hea0000875","article-title":"The novel coronavirus (COVID-2019) outbreak: Amplification of public health consequences by media exposure","volume":"39","author":"Garfin","year":"2020","journal-title":"Health Psychol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s10597-020-00728-y","article-title":"Prevalence, psychological responses and associated correlates of depression, anxiety and stress in a global population, during the coronavirus disease (COVID-19) pandemic","volume":"57","author":"Shah","year":"2021","journal-title":"Community Ment Health J"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1177\/17456916221078310","article-title":"Examination of the COVID-19 pandemic\u2019s impact on mental health from three perspectives: global, social, and individual","volume":"18","author":"Thomas","year":"2023","journal-title":"Perspect Psychol Sci"},{"key":"B4","doi-asserted-by":"publisher","first-page":"102598","DOI":"10.1016\/j.janxdis.2022.102598","article-title":"Anxiety disorders, COVID-19 fear, and vaccine hesitancy","volume":"90","author":"McNeil","year":"2022","journal-title":"J Anxiety Disord"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.07.048","article-title":"Risk of anaphylaxis after vaccination in children and adults","volume":"137","author":"McNeil","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.anai.2022.03.030","article-title":"What have we learned about the allergenicity and adverse reactions associated with the severe acute respiratory syndrome coronavirus 2 vaccines: One year later","volume":"129","author":"Copaescu","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.3390\/vaccines10122047","article-title":"Interactions between severe allergy and anxiety in anti-SARS-CoV-2 vaccinees","volume":"10","author":"Asperti","year":"2022","journal-title":"Vaccines"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2020.12.020","article-title":"Anaphylaxis to the first COVID-19 vaccine: is polyethylene glycol (PEG) the culprit","volume":"126","author":"Garvey","year":"2021","journal-title":"Br J Anaesth"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2020.09.029","article-title":"Polyethylene glycol\u2013induced systemic allergic reactions (Anaphylaxis)","volume":"9","author":"Sellaturay","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B10","doi-asserted-by":"publisher","first-page":"100654","DOI":"10.1016\/j.waojou.2022.100654","article-title":"Second-dose COVID-19 vaccines are well tolerated in patients with allergic reactions to the first dose \u2013 a single center experience","volume":"15","author":"Puxkandl","year":"2022","journal-title":"World Allergy Organ J"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2007.12.002","article-title":"Personality characteristics in chronic and non-chronic allergic conditions","volume":"22","author":"Buske-Kirschbaum","year":"2008","journal-title":"Brain Behav Immun"},{"key":"B12","doi-asserted-by":"publisher","first-page":"100510","DOI":"10.1016\/j.waojou.2021.100510","article-title":"Psychological impact of the COVID-19 pandemic on patients with allergic diseases","volume":"14","author":"Gonzalez-Diaz","year":"2021","journal-title":"World Allergy Organ J"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.12932\/AP-140820-0941","article-title":"Anxiety and depression in allergic rhinitis patients during COVID-19 pandemic in Wuhan, China","volume":"40","author":"Wang","year":"2022","journal-title":"Asian Pac J Allergy Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(77)91953-5","article-title":"Incidence and severity of anaphylactoid reactions to colloid volume substitutes","volume":"309","author":"Ring","year":"1977","journal-title":"Lancet"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000646","article-title":"Updated diagnostic criteria and classification of mast cell disorders: A consensus proposal","volume":"5","author":"Valent","year":"2021","journal-title":"HemaSphere"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.31034","article-title":"Association of self-reported high-risk allergy history with allergy symptoms after COVID-19 vaccination","volume":"4","author":"Li","year":"2021","journal-title":"JAMA Netw Open"},{"key":"B18","doi-asserted-by":"publisher","first-page":"100079","DOI":"10.1016\/j.jacig.2023.100079","article-title":"Vaccine confidence among those living with allergy during the COVID pandemic (ACCORD): A scoping review","volume":"2","author":"Batac","year":"2023","journal-title":"J Allergy Clin Immunol Glob"},{"key":"B19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s40629-021-00165-7","article-title":"Practical handling of allergic reactions to COVID-19 vaccines: A position paper from German and Austrian Allergy Societies AeDA, DGAKI, GPA and \u00d6GAI","volume":"30","author":"Klimek","year":"2021","journal-title":"Allergo J Int"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2022.01.037","article-title":"COVID-19 vaccination in the setting of mastocytosis\u2014Pfizer-BioNTech mRNA vaccine is safe and well tolerated","volume":"10","author":"Lazarinis","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2016.12.012","article-title":"Psychometric evaluation of the Generalized Anxiety Disorder Screener GAD-7, based on a large German general population sample","volume":"210","author":"Hinz","year":"2017","journal-title":"J Affect Disord"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2022.05.079","article-title":"Equating the PHQ-9 and GAD-7 to the HADS depression and anxiety subscales in patients with major depressive disorder","volume":"311","author":"Huang","year":"2022","journal-title":"J Affect Disord"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1007\/s00296-017-3819-x","article-title":"Assessment of the Hospital Anxiety and Depression Scale (HADS) performance for the diagnosis of anxiety in patients with systemic lupus erythematosus","volume":"37","author":"de Almeida Mac\u00eado","year":"2017","journal-title":"Rheumatol Int"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1177\/0961203317713142","article-title":"Depression in systemic lupus erythematosus: gender differences in the performance of the Beck Depression Inventory (BDI), Center for Epidemiologic Studies Depression Scale (CES-D), and Hospital Anxiety and Depression Scale (HADS)","volume":"27","author":"Mac\u00eado","year":"2018","journal-title":"Lupus"},{"key":"B25","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1037\/bul0000102","article-title":"Gender differences in depression in representative national samples: Meta-analyses of diagnoses and symptoms","volume":"143","author":"Salk","year":"2017","journal-title":"Psychol Bull August"},{"key":"B26","doi-asserted-by":"publisher","first-page":"107724","DOI":"10.1016\/j.intimp.2021.107724","article-title":"COVID-19 vaccine hesitancy and related fears and anxiety","volume":"97","author":"Bendau","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2019.320","article-title":"Anxiety, depression, and stress in Korean patients with chronic urticaria","volume":"35","author":"Choi","year":"2020","journal-title":"Korean J Intern Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.3390\/vaccines10081356","article-title":"Global prevalence and potential influencing factors of COVID-19 vaccination hesitancy: A meta-analysis","volume":"10","author":"Fajar","year":"2022","journal-title":"Vaccines"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1324987\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T04:25:13Z","timestamp":1715919913000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1324987\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,17]]},"references-count":28,"alternative-id":["10.3389\/fimmu.2024.1324987"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1324987","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,17]]},"article-number":"1324987"}}